PHARMACY

Cystic fibrosis treatment now available through Diplomat Pharmacy

BY Michael Johnsen

FLINT, Mich. — As part of a limited panel, Diplomat Pharmacy will offer PARI’s cystic fibrosis treatment Kitabis Pak, a 28-day supply of Tobramycin Inhalation Solution together with a PARI LC Plus nebulizer handset, the specialty pharmacy operator announced Tuesday.
 
Kitabis Pak is an FDA-approved drug-and-device combination for cystic fibrosis, and the first to use nebulized tobramycin, an inhalable antibiotic. 
 
“This unique offering can simplify the process for prescribers and patients facing cystic fibrosis,” said Gary Kadlec, president of Diplomat. “Now, physicians can write a single prescription and be sure their patients are receiving their treatments with the nebulizer handset used during the pivotal clinical trials. We’re excited to be able to offer it, for improved access, adherence and efficacy.”
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

HRG to present to Campbell University pharmacy students for seventh consecutive year

BY Antoinette Alexander

 

Hamacher Resource Group's Tom Boyer

WAUKESHA, Wis. — Hamacher Resource Group has announced that Tom Boyer will present to first-year students in the Pharmacy Practice program at Campbell University in Buies Creek, N.C., for the seventh consecutive year.

On March 25, Boyer, a 20-plus-year veteran of the retail consumer healthcare industry, director of national accounts, and member of the owners group at HRG, will discuss the retail pharmacy side of the business, including pharmacy layout and front-of-store merchandising principles.


Boyer’s connection with Campbell University began through his relationship with Mutual Drug, Durham, N.C., which has been an HRG client for 33 years and Hamacher’s first wholesaler client. Boyer learned of Mutual Drug’s relationship with Campbell University, among other pharmacy schools it supports, back in 2008. Boyer, who conducts CE sessions for pharmacists at industry events, offered guest lecturer support to the pharmacy school and has been asked back every spring.

“I’m glad we could facilitate this long-standing relationship between HRG and the College of Pharmacy & Health Sciences at Campbell University. We believe it’s important to expose future pharmacists to the business aspects of running a pharmacy — both the opportunities and challenges,” stated David Moody, Mutual Drug CEO.

Boyer added, “It has been a pleasure to present to a new class of pharmacy students each year. I enjoy hearing their perspectives and getting their feedback. I’m grateful that Mutual Drug brought this opportunity forward and that we can help support something we both are passionate about.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Par prepares for IPO

BY Ryan Chavis

CHESTNUT RIDGE, N.Y. — Par Pharmaceutical Holdings last week announced that it filed a statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock. The number of shares offered by the company and its shareholders, along with the price, haven’t been determined, according to a statement from Par. 
 
J.P. Morgan and Goldman, Sachs & Co. are working as joint managers as well as representatives of the underwriters for the proposed IPO. Additionally, Citigroup, Morgan Stanley, BofA Merrill Lynch, Deutsche Bank Securities and Evercore ISI are joint book-running managers for the offering, according to Par. 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?